BackUROLOGIX ORD SHS Overview

UROLOGIX ORD SHS Profit Margin

UROLOGIX ORD SHS (ULGX) has a profit margin of -38.29%, below the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-12.48%
↑ 74.83% YoY

As of Mar 2015

Annual Profit Margin (TTM)

-38.29%
↓ 8.67% YoY

Trailing 12 months ending Mar 2015

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

UROLOGIX ORD SHS (ULGX) FAQ

UROLOGIX ORD SHS posts a profit margin of -38.29% as of March 2015. That compares with -35.24% in the prior-year period — down 8.7% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, UROLOGIX ORD SHS's profit margin was -35.24%. The latest reading is -38.29% — a 8.7% year-over-year decrease (period ending March 2015). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a profit margin near 13.4% is typical. UROLOGIX ORD SHS's -38.29% is lower that level. That is roughly 385.7% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

UROLOGIX ORD SHS's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -38.29% as of March 2015; use YoY and peer views to separate noise from signal.

Context for ULGX's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; UROLOGIX ORD SHS's other metric pages and overview cover the third.